Acute cholecystitis other imaging findings

Revision as of 20:43, 11 December 2017 by Furqan M Muhammad (talk | contribs)
Jump to navigation Jump to search

Acute cholecystitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute cholecystitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Acute cholecystitis other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute cholecystitis other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute cholecystitis other imaging findings

CDC on Acute cholecystitis other imaging findings

Acute cholecystitis other imaging findings in the news

Blogs on Acute cholecystitis other imaging findings

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Acute cholecystitis other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]

Overview

Cholescintigraphy which utilizes technetium-labeled hepatic 2,6-dimethyl-iminodiacetic acid (HIDA) may be helpful in the diagnosis of acute cholecystitis. Findings on a cholescintigraphy diagnostic of acute cholecystitis include lack of visualization of the gallbladder.

Other Imaging Findings

  • Cholescintigraphy which utilizes technetium-labeled hepatic 2,6-dimethyl-iminodiacetic acid (HIDA) may be helpful in the diagnosis of acute cholecystitis.
  • Findings on a cholescintigraphy diagnostic of acute cholecystitis include:
    • No visualization of the gallbladder
    • Superior sensitivity to ultrasound
(see Fig. 3B). The main advantage of HIDA is its superior sensitivity in diagnosing acute cholecystitis. However, there are several disadvantages. Compared with US, cholescintigraphy is more expensive, time intensive (it takes several hours compared with 10–15 minutes for US), requires skilled staff, and is often not available after hours. It also exposes patients to ionizing radiation and provides information limited to the hepatobiliary system, whereas US and MRI do not expose patients to radiation and can provide added information outside the hepatobiliary system.

References

Template:WH Template:WS